SYRS logo

Syros Pharmaceuticals (SYRS) Company Overview

Profile

Full Name:

Syros Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 30, 2016

Indexes:

Not included

Description:

Syros Pharmaceuticals is a biotechnology company focused on developing innovative medicines for cancer and genetic diseases. They use their expertise in gene control to create targeted therapies that aim to improve patient outcomes and address unmet medical needs in oncology and rare diseases.

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Oct 31, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 19, 2022

Analyst ratings

Recent major analysts updates

Nov 13, 24 TD Cowen
Hold
Nov 13, 24 JMP Securities
Market Perform
Nov 13, 24 HC Wainwright & Co.
Neutral
Nov 13, 24 Brookline Capital
Hold
Nov 1, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Piper Sandler
Overweight
Aug 13, 24 JMP Securities
Market Outperform
Aug 13, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jun 26, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Syros Pharmaceuticals?
  • Does Syros Pharmaceuticals pay dividends?
  • What sector is Syros Pharmaceuticals in?
  • What industry is Syros Pharmaceuticals in?
  • What country is Syros Pharmaceuticals based in?
  • When did Syros Pharmaceuticals go public?
  • Is Syros Pharmaceuticals in the S&P 500?
  • Is Syros Pharmaceuticals in the NASDAQ 100?
  • Is Syros Pharmaceuticals in the Dow Jones?
  • When was Syros Pharmaceuticals's last earnings report?
  • When does Syros Pharmaceuticals report earnings?
  • Should I buy Syros Pharmaceuticals stock now?

What is the ticker symbol for Syros Pharmaceuticals?

The ticker symbol for Syros Pharmaceuticals is NASDAQ:SYRS

Does Syros Pharmaceuticals pay dividends?

No, Syros Pharmaceuticals does not pay dividends

What sector is Syros Pharmaceuticals in?

Syros Pharmaceuticals is in the Healthcare sector

What industry is Syros Pharmaceuticals in?

Syros Pharmaceuticals is in the Biotechnology industry

What country is Syros Pharmaceuticals based in?

Syros Pharmaceuticals is headquartered in United States

When did Syros Pharmaceuticals go public?

Syros Pharmaceuticals's initial public offering (IPO) was on June 30, 2016

Is Syros Pharmaceuticals in the S&P 500?

No, Syros Pharmaceuticals is not included in the S&P 500 index

Is Syros Pharmaceuticals in the NASDAQ 100?

No, Syros Pharmaceuticals is not included in the NASDAQ 100 index

Is Syros Pharmaceuticals in the Dow Jones?

No, Syros Pharmaceuticals is not included in the Dow Jones index

When was Syros Pharmaceuticals's last earnings report?

Syros Pharmaceuticals's most recent earnings report was on Oct 31, 2024

When does Syros Pharmaceuticals report earnings?

The next expected earnings date for Syros Pharmaceuticals is Mar 27, 2025

Should I buy Syros Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions